| Item Type | Name |
|
Concept
|
Blood Flow Velocity
|
|
Concept
|
Blood Pressure
|
|
Concept
|
Blood Glucose
|
|
Concept
|
Blood Pressure Determination
|
|
Concept
|
Blood Pressure Monitoring, Ambulatory
|
|
Academic Article
|
Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension.
|
|
Academic Article
|
Pharmacogenomic Genome-Wide Meta-Analysis of Blood Pressure Response to ß-Blockers in Hypertensive African Americans.
|
|
Academic Article
|
Blood pressure in early autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Pharmacogenomics of hypertension: a genome-wide, placebo-controlled cross-over study, using four classes of antihypertensive drugs.
|
|
Academic Article
|
Is diabetes mellitus-linked amino acid signature associated with ß-blocker-induced impaired fasting glucose?
|
|
Academic Article
|
Lack of association between polymorphisms in STK39, a putative thiazide response gene, and blood pressure response to hydrochlorothiazide.
|
|
Academic Article
|
Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic.
|
|
Academic Article
|
Lack of agreement between office and ambulatory blood pressure responses to hydrochlorothiazide.
|
|
Academic Article
|
Baseline predictors of central aortic blood pressure: a PEAR substudy.
|
|
Academic Article
|
Reproducibility of blood pressure response to hydrochlorothiazide.
|
|
Academic Article
|
Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.
|
|
Academic Article
|
Demographic, environmental, and genetic predictors of metabolic side effects of hydrochlorothiazide treatment in hypertensive subjects.
|
|
Academic Article
|
PTPRD gene associated with blood pressure response to atenolol and resistant hypertension.
|
|
Academic Article
|
A multilocus approach to the antihypertensive pharmacogenetics of hydrochlorothiazide.
|
|
Academic Article
|
WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic.
|
|
Academic Article
|
Effects of endothelial nitric oxide synthase, alpha-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide.
|
|
Academic Article
|
Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis.
|
|
Academic Article
|
Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study.
|
|
Academic Article
|
Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazide.
|
|
Academic Article
|
Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide.
|
|
Academic Article
|
Large-scale gene-centric analysis identifies polymorphisms for resistant hypertension.
|
|
Academic Article
|
PROX1 gene variant is associated with fasting glucose change after antihypertensive treatment.
|
|
Academic Article
|
TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives.
|
|
Academic Article
|
Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study.
|
|
Academic Article
|
Predictors of blood pressure response to the angiotensin receptor blocker candesartan in essential hypertension.
|
|
Academic Article
|
Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients.
|
|
Academic Article
|
Association of branched and aromatic amino acids levels with metabolic syndrome and impaired fasting glucose in hypertensive patients.
|
|
Academic Article
|
Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response.
|
|
Academic Article
|
Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide.
|
|
Academic Article
|
Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension.
|
|
Academic Article
|
G protein receptor kinase 4 polymorphisms: ß-blocker pharmacogenetics and treatment-related outcomes in hypertension.
|
|
Academic Article
|
Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide.
|
|
Academic Article
|
Angiotensin blockade in late autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Urate transporter gene SLC22A12 polymorphisms associated with obesity and metabolic syndrome in Caucasians with hypertension.
|
|
Academic Article
|
Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.
|
|
Academic Article
|
Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker.
|
|
Academic Article
|
Lack of correlation between thiazide-induced hyperglycemia and hypokalemia: subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.
|
|
Academic Article
|
Comparison of office, ambulatory, and home blood pressure antihypertensive response to atenolol and hydrochlorthiazide.
|
|
Academic Article
|
Analysis of baseline parameters in the HALT polycystic kidney disease trials.
|
|
Academic Article
|
Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.
|
|
Academic Article
|
A Genetic Response Score for Hydrochlorothiazide Use: Insights From Genomics and Metabolomics Integration.
|
|
Academic Article
|
Renal volume in children with ADPKD: size matters.
|
|
Academic Article
|
Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies.
|
|
Academic Article
|
The role of parental hypertension in the frequency and age of diagnosis of hypertension in offspring with autosomal-dominant polycystic kidney disease.
|
|
Academic Article
|
Comparison of Blood Pressure Control Rates Among Recommended Drug Selection Strategies for Initial Therapy of Hypertension.
|
|
Academic Article
|
Blood pressure responses and metabolic effects of hydrochlorothiazide and atenolol.
|
|
Academic Article
|
Night blood pressure responses to atenolol and hydrochlorothiazide in black and white patients with essential hypertension.
|
|
Academic Article
|
Genome-Wide and Gene-Based Meta-Analyses Identify Novel Loci Influencing Blood Pressure Response to Hydrochlorothiazide.
|
|
Academic Article
|
Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial.
|
|
Academic Article
|
Genome-Wide Prioritization and Transcriptomics Reveal Novel Signatures Associated With Thiazide Diuretics Blood Pressure Response.
|
|
Academic Article
|
Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics.
|
|
Academic Article
|
Whole Transcriptome Sequencing Analyses Reveal Molecular Markers of Blood Pressure Response to Thiazide Diuretics.
|
|
Academic Article
|
Genome Wide Association Study Identifies the HMGCS2 Locus to be Associated With Chlorthalidone Induced Glucose Increase in Hypertensive Patients.
|
|
Academic Article
|
Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses).
|
|
Academic Article
|
Blood pressure response to metoprolol and chlorthalidone in European and African Americans with hypertension.
|
|
Academic Article
|
Blood pressure signature genes and blood pressure response to thiazide diuretics: results from the PEAR and PEAR-2 studies.
|
|
Academic Article
|
Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/ß-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
|
|
Academic Article
|
Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?
|
|
Academic Article
|
Targeted sequencing identifies a missense variant in the BEST3 gene associated with antihypertensive response to hydrochlorothiazide.
|
|
Academic Article
|
Renal arterial blood flow measurement by breath-held MRI: Accuracy in phantom scans and reproducibility in healthy subjects.
|
|
Academic Article
|
Plasma Renin Activity Is a Predictive Biomarker of Blood Pressure Response in European but not in African Americans With Uncomplicated Hypertension.
|
|
Academic Article
|
The future of pharmacogenetics in the treatment of hypertension.
|
|
Academic Article
|
Genomic Association Analysis Reveals Variants Associated With Blood Pressure Response to Beta-Blockers in European Americans.
|
|
Academic Article
|
Genome-Wide Meta-Analysis of Blood Pressure Response to ß1-Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies).
|
|
Academic Article
|
Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers.
|
|
Academic Article
|
Genome Wide Analysis Approach Suggests Chromosome 2 Locus to be Associated with Thiazide and Thiazide Like-Diuretics Blood Pressure Response.
|
|
Academic Article
|
Response to: Heterogeneous Treatment Response by Race Cannot Be Claimed in the Absence of Evidence.
|
|
Academic Article
|
Range and Variability of Outcomes Reported in Randomized Trials Conducted in Patients With Polycystic Kidney Disease: A Systematic Review.
|
|
Academic Article
|
Sorting nexin 1 loss results in increased oxidative stress and hypertension.
|
|
Academic Article
|
Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype-Derived Activity Scores.
|
|
Academic Article
|
Metabolomics Signature of Plasma Renin Activity and Linkage with Blood Pressure Response to Beta Blockers and Thiazide Diuretics in Hypertensive European American Patients.
|
|
Academic Article
|
Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions.
|
|
Grant
|
Melatonin and Nighttime Blood Pressure in African Americans
|
|
Grant
|
Limited Competition: Clinical Centers for the HALT-Polycystic Kidney Disease Tria
|
|
Grant
|
Limited Competition for the Continuation of the Consortium for Radiologic Imaging
|
|
Academic Article
|
Circulating microRNA Biomarkers of Thiazide Response in Hypertension.
|